Edition:
United States

EyeGate Pharmaceuticals Inc (EYEG.OQ)

EYEG.OQ on NASDAQ Stock Exchange Capital Market

0.49USD
17 Jan 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.49
Open
$0.49
Day's High
$0.50
Day's Low
$0.46
Volume
54,137
Avg. Vol
228,658
52-wk High
$1.27
52-wk Low
$0.28

Chart for

About

Eyegate Pharmaceuticals, Inc. is a clinical-stage specialty pharmaceutical company. The Company is focused on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The Company's lead product, EGP-437, incorporates a reformulated topically active corticosteroid, dexamethasone... (more)

Overall

Beta: --
Market Cap(Mil.): $20.99
Shares Outstanding(Mil.): 17.20
Dividend: --
Yield (%): --

Financials

  EYEG.OQ Industry Sector
P/E (TTM): -- 30.48 33.71
EPS (TTM): -1.30 -- --
ROI: -193.34 14.98 14.48
ROE: -241.44 16.31 15.99

Earnings vs. Estimates